Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001494650-18-000091)

Filing Details

Accession Number:: 0001494650-18-000091
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-15 14:36:10
Reporting Period:: 2018-08-15

Accepted Time:: 2018-08-15 14:36:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494650	Optinose Inc.	OPTN	Pharmaceutical Preparations (2834)	421771610

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639012	Edward Thomas Gibbs	C/O Optinose, Inc. 1020 Stony Hill Road, Suite 300 Yardley PA 19067	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-15	2,000	$12.69	3,985	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Includes 1,985 shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on June 29, 2018 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).